Skip to main content

CEO of SFDA Meets with Mauritanian Health Minister

2022-12-26

His Excellency the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Aljadhey, met today at the authority’s headquarters in Riyadh, His Excellency the Minister of Health of the Islamic Republic of Mauritania, Moktar Ould Dahi and his accompanying delegation, in the presence of the Ambassador of the Republic of Mauritania to the Kingdom Sidi Ali.

Other News

SFDA Participates in International Gathering to Harmonize Technical Needs for Human Medicines

2022-12-01

Saudi Food and Drug Authority (SFDA) has participated in the 45th semi-annual meeting of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), which was held in Incheon, South Korea, with the participation of Saudi specialists and experts.

Other News

Drug Master File : Guidance for Submission

2022-11-29
Drug Master File : Guidance for Submission
Has the page content helped you?

Guidance on Publication of Public Assessment Reports for Medicinal Products for Human Use (Saudi-PAR)

2022-11-13
Guidance on Publication of Public Assessment Reports for Medicinal Products for Human Use (Saudi-PAR)
Guide
Has the page content helped you?

Conditional Approval for Medicinal Products for Human Use

2023-10-24
Conditional Approval for Medicinal Products for Human Use
Guide
Has the page content helped you?

Dr. Aljadhey Heads Saudi Delegation Participating in ICMRA Summit in Ireland

2022-11-09

His Excellence the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Aljadhey, headed the Kingdom of Saudi Arabia’s delegation participating in the annual summit of the International Coalition of Medicines Regulatory Authorities (ICMRA) held in Ireland.

Other News

SFDA Explores Cooperation Opportunities with Irish National Institute for Bioprocessing Research and Training

2022-11-08

The Saudi Food and Drug Authority has explored opportunities to benefit from the experience of the National Institute for Bioprocessing Research and Training (NIBRT) in Dublin in supporting local biotechnology companies, with the aim of transferring these successful experiences to the Kingdom.

This came during the visit of a delegation from the Authority headed by His Excellency the CEO, Dr. Hisham bin Saad Aljadhey, to the institute, aiming at strengthening relations with similar international bodies.

Other News

SFDA’s CEO Meets with President of German Paul-Ehrlich-Institut

2022-11-07

His Excellency the CEO of the Saudi Food and Drug Authority (SFDA) Dr. Hisham bin Saad Al-Jadhey met recently with President of Paul-Ehrlich-Institut (PEI) Dr. Klaus Cichutek.
During the meeting, they discussed ways of joint cooperation between the two sides in the field of controlling vital medicines and its laboratories, research and training, and exchanging knowledge and scientific consultations.

Other News

Good regulatory practice

2022-10-27
Good regulatory practice
List
Has the page content helped you?
Subscribe to Drugs